Viral-induced neuronal necroptosis: Detrimental to brain function and regulation by necroptosis inhibitors.


Journal

Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032

Informations de publication

Date de publication:
07 2023
Historique:
received: 17 03 2023
revised: 09 05 2023
accepted: 10 05 2023
medline: 19 6 2023
pubmed: 18 5 2023
entrez: 17 5 2023
Statut: ppublish

Résumé

Neuronal necroptosis (programmed necrosis) in the CNS naturally occurs through a caspase-independent way and, especially in neurodegenerative diseases (NDDs) such as Alzheimer's disease (AD), Parknson's disease (PD), Amyotrophic Lateral Sclerosis (ALS) and viral infections. Understanding necroptosis pathways (death receptor-dependent and independent), and its connections with other cell death pathways could lead to new insights into treatment. Receptor-interacting protein kinase (RIPK) mediates necroptosis via mixed-lineage kinase-like (MLKL) proteins. RIPK/MLKL necrosome contains FADD, procaspase-8-cellular FLICE-inhibitory proteins (cFLIPs), RIPK1/RIPK3, and MLKL. The necrotic stimuli cause phosphorylation of MLKL and translocate to the plasma membrane, causing an influx of Ca

Identifiants

pubmed: 37196683
pii: S0006-2952(23)00182-X
doi: 10.1016/j.bcp.2023.115591
pii:
doi:

Substances chimiques

Protein Kinases EC 2.7.-
Inflammasomes 0
NLR Family, Pyrin Domain-Containing 3 Protein 0
Caspase 1 EC 3.4.22.36
Receptors, Death Domain 0
Interleukin-1 0
Receptor-Interacting Protein Serine-Threonine Kinases EC 2.7.11.1
MIRN512 microRNA, human 0
MicroRNAs 0
MIRN874 microRNA, human 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

115591

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Siva Prasad Panda (S)

Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India. Electronic address: sivaprasad.panda@gla.ac.in.

Adarsh Kesharwani (A)

Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India.

Sarada Prasanna Mallick (S)

Department of Biotechnology, Koneru Lakshmaiah Education Foundation, Guntur, Andhrapradesh, India.

Dsnbk Prasanth (D)

Department of Pharmacognosy, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, AP, India.

Praveen Kumar Pasala (P)

Santhiram College of Pharmacy, JNTUA, Nandyl, Andhra Pradesh, India.

Vinay Bharadwaj Tatipamula (V)

Center for Molecular Biology, College of Medicine and Pharmacy, Duy Tan University, Danang 550000, Viet Nam.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH